Identification of genetic alterations related to chemoresistance in epithelial ovarian cancer

This publication has 22 references indexed in Scilit:

• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Phase III Randomized Study of Cisplatin Versus Paclitaxel Versus Cisplatin and Paclitaxel in Patients With Suboptimal Stage III or IV Ovarian Cancer: A Gynecologic Oncology Group Study
  Journal of Clinical Oncology, 2000
• Evidence that a "treatment-free interval of less than 6 months" does not equate with clinically defined platinum resistance in ovarian cancer or primary peritoneal carcinoma
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1998
• Chemotherapy resistance in ovarian cancer: New molecular perspectives
  Published by Wolters Kluwer Health ,1998
• Comparative genomic hybridization analysis of chromosomal changes occurring during development of acquired resistance to cisplatin in human ovarian carcinoma cells
  Genes, Chromosomes and Cancer, 1997
• Use of a cDNA microarray to analyse gene expression patterns in human cancer
  Nature Genetics, 1996
• A novel method for real time quantitative RT-PCR.
  Genome Research, 1996
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
  Science, 1992
• Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase.
  Proceedings of the National Academy of Sciences, 1991